agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $1.23 billion. The enterprise value is $904.37 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 413.95 million shares outstanding. The number of shares has increased by 1.01% in one year.
| Current Share Class | 413.95M |
| Shares Outstanding | 413.95M |
| Shares Change (YoY) | +1.01% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 70.38% |
| Float | 307.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| Forward PS | 0.20 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 3.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.20 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.94 |
Financial Efficiency
Return on equity (ROE) is -42.97% and return on invested capital (ROIC) is -29.40%.
| Return on Equity (ROE) | -42.97% |
| Return on Assets (ROA) | -8.85% |
| Return on Invested Capital (ROIC) | -29.40% |
| Return on Capital Employed (ROCE) | -53.89% |
| Revenue Per Employee | $5.57M |
| Profits Per Employee | -$224,884 |
| Employee Count | 1,076 |
| Asset Turnover | 2.82 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.78 million in taxes.
| Income Tax | 1.78M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.77% in the last 52 weeks. The beta is 0.39, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -42.77% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 35.23 |
| Average Volume (20 Days) | 6,184,883 |
Short Selling Information
The latest short interest is 19.13 million, so 4.62% of the outstanding shares have been sold short.
| Short Interest | 19.13M |
| Short Previous Month | 18.56M |
| Short % of Shares Out | 4.62% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, agilon health had revenue of $5.99 billion and -$241.98 million in losses. Loss per share was -$0.59.
| Revenue | 5.99B |
| Gross Profit | -19.53M |
| Operating Income | -300.78M |
| Pretax Income | -296.85M |
| Net Income | -241.98M |
| EBITDA | -275.28M |
| EBIT | -300.78M |
| Loss Per Share | -$0.59 |
Full Income StatementBalance Sheet
The company has $367.08 million in cash and $42.02 million in debt, giving a net cash position of $325.07 million or $0.79 per share.
| Cash & Cash Equivalents | 367.08M |
| Total Debt | 42.02M |
| Net Cash | 325.07M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 500.25M |
| Book Value Per Share | 1.21 |
| Working Capital | 276.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.99 million and capital expenditures -$13.96 million, giving a free cash flow of -$55.95 million.
| Operating Cash Flow | -41.99M |
| Capital Expenditures | -13.96M |
| Free Cash Flow | -55.95M |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is -0.33%, with operating and profit margins of -5.02% and -4.04%.
| Gross Margin | -0.33% |
| Operating Margin | -5.02% |
| Pretax Margin | -4.23% |
| Profit Margin | -4.04% |
| EBITDA Margin | -4.60% |
| EBIT Margin | -5.02% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.01% |
| Shareholder Yield | -1.01% |
| Earnings Yield | -19.68% |
| FCF Yield | -4.55% |
Dividend DetailsAnalyst Forecast
The average price target for agilon health is $4.56, which is 53.54% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.56 |
| Price Target Difference | 53.54% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 10.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 2.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | 2 |